Darron Lewis, MD
Interventional Cardiology · Port St Lucie, FLNPI 1962505206
Payments from drug & device makers
Across 356 payments — averaging $74.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Abbott$8K
- Edwards Lifesciences$1K
- Boston Scientific$977
- Penumbra, Inc.$925
- Cardiovascular Systems Inc.$788
- plus $4K from 26 others
What the payments were for
- Consulting fees$4302%
- Travel & lodging$11,85445%
- Food & beverage$13,83653%
- Education$1791%
- Other$440%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 75 | $10,538 |
| Abbott | 114 | $7,739 |
| Edwards Lifesciences | 11 | $1,369 |
| Boston Scientific | 8 | $977 |
| Penumbra, Inc. | 7 | $925 |
| Cardiovascular Systems Inc. | 12 | $788 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $713 |
| Johnson & Johnson | 17 | $434 |
| Astellas Pharma US Inc | 10 | $422 |
| Amgen | 13 | $373 |
| Novartis | 10 | $278 |
| Pfizer | 14 | $270 |
| Viiv Healthcare Company | 2 | $249 |
| Kestra Medical Technology Services, Inc. | 6 | $195 |
| E.r. Squibb & Sons, L.L.C. | 9 | $158 |
| Biosense Webster, Inc. | 1 | $124 |
| Gilead | 1 | $120 |
| Omega Medical Imaging, LLC | 1 | $112 |
| Cardinal Health 200 LLC | 1 | $85 |
| Cvrx, Inc. | 2 | $68 |
| Shockwave Medical, Inc | 3 | $62 |
| Welch Allyn | 1 | $44 |
| Vital Connect, Inc | 2 | $42 |
| AstraZeneca | 3 | $38 |
| Cardiva Medical, Inc. | 2 | $37 |
| CSL Behring | 1 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Atricure, Inc. | 1 | $33 |
| Baxter Healthcare | 2 | $30 |
| Inari Medical, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $13 |
| Terumo Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolute$6,773
- OPTIS$2,300
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,012
- SUPERA$915
- Indigo System$891
- VersaCross Access Solution$855
- AMPLATZER AMULET$734
- Optis Coronary Imaging System$725
- LINQ II$423
- Coronary Orbital Atherectomy System$415
- AZURE XT DR MRI SURESCAN$394
- COREVALVE EVOLUT R$378
- HI-TORQUE BALANCE$366
- DOVATO$249
- Claria MRI$232
- XARELTO$230
- XIENCE SIERRA$181
- Mitra Clip system$167
- DRAGONFLY OPSTAR$150
- Diamondback Coronary$147
How this compares
$26,343 in reported general payments places this provider in the 70th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 188 | $194,040 |
| EntrestoSacubitril/Valsartan | 68 | $98,495 |
| XareltoRivaroxaban | 14 | $13,308 |
| Carvedilol | 306 | $2,574 |
| Prasugrel Hcl | 28 | $2,127 |
| Telmisartan | 58 | $1,899 |
| Atorvastatin Calcium | 144 | $1,749 |
| Amlodipine Besylate | 309 | $1,649 |
| Ranolazine ErRanolazine | 17 | $1,483 |
| Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid | 14 | $1,419 |
| Dilt-XrDiltiazem Hcl | 18 | $902 |
| Rosuvastatin Calcium | 22 | $729 |
| Metoprolol Tartrate | 54 | $288 |
| ClopidogrelClopidogrel Bisulfate | 41 | $287 |
| Bumetanide | 11 | $278 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $270 | $194,040188 claims |
| NovartisEntresto | $278 | $98,49568 claims |
| Johnson & JohnsonXarelto | $434 | $13,30814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Port St Lucie
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
- Ruby SatpathyJacksonville$1.8M
- Santhosh MathewsBradenton$1.7M
- Pedro Martinez-ClarkMiami$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.